Testing the Decision Support Tool for Responsible Pain Management for Headache and Facial Pain Diagnosis with Opioid-Risk-Stratified Treatment.

Barbara St Marie, Yelena Perkhounkova, Amalia Gedney-Lose, Andrea Jimmerson, Brooke Porter, Keela Herr, Prakash Nadkarni
Author Information
  1. Barbara St Marie: College of Nursing, University of Iowa, 50 Newton Road, Iowa City, IA 52242 USA. ORCID
  2. Yelena Perkhounkova: College of Nursing, Biostatistics, University of Iowa, 50 Newton Road, Iowa City, IA 52242 USA.
  3. Amalia Gedney-Lose: College of Nursing, University of Iowa, 50 Newton Road, Iowa City, IA 52242 USA.
  4. Andrea Jimmerson: College of Nursing, University of Iowa, 50 Newton Road, Iowa City, IA 52242 USA.
  5. Brooke Porter: College of Nursing, University of Iowa, 50 Newton Road, Iowa City, IA 52242 USA.
  6. Keela Herr: College of Nursing, University of Iowa, 50 Newton Road, Iowa City, IA 52242 USA.
  7. Prakash Nadkarni: Internal Medicine, University of Iowa, Iowa City, IA 52242 USA.

Abstract

In primary and urgent care, headache and facial pain are common and challenging to diagnose and manage, especially with using opioids appropriately. We therefore developed the Decision Support Tool for Responsible Pain Management (DS-RPM) to assist healthcare providers in diagnosis (including multiple simultaneous diagnoses), workup (including triage), and opioid-risk-informed treatment. A primary goal was to supply sufficient explanations of DS-RPM's functions allowing critique. We describe the process of iteratively designing DS-RPM adding clinical content and testing/defect discovery. We tested DS-RPM remotely with 21 clinician-participants using three vignettes-cluster headache, migraine, and temporal arteritis-after first training to use DS-RPM with a trigeminal-neuralgia vignette. Their evaluation was both quantitative (usability/acceptability) and qualitative using semi-structured interviews. The quantitative evaluation used 12 Likert-type questions on a 1-5 scale, where 5 represented the highest rating. The mean ratings ranged from 4.48 to 4.95 (SDs ranging 0.22-1.03). Participants initially found structured data entry intimidating but adapted and appreciated its comprehensiveness and speed of data capture. They perceived DS-RPM as useful for teaching and clinical practice, making several enhancement suggestions. The DS-RPM was designed, created, and tested to facilitate best practice in management of patients with headaches and facial pain. Testing the DS-RPM with vignettes showed strong functionality and high usability/acceptability ratings from healthcare providers. Risk stratifying for opioid use disorder to develop a treatment plan for headache and facial pain is possible using vignettes. During testing, we considered the need to adapt usability/acceptability evaluation tools for clinical decision support, and future directions.

Keywords

References

  1. JAMA. 2016 Apr 19;315(15):1624-45 [PMID: 26977696]
  2. J Back Musculoskelet Rehabil. 2018 Feb 6;31(1):197-204 [PMID: 28854501]
  3. J Med Toxicol. 2016 Sep;12(3):282-8 [PMID: 27150104]
  4. Eye Brain. 2016 Oct 26;8:195-202 [PMID: 28539814]
  5. J Am Board Fam Med. 2013 Jul-Aug;26(4):394-400 [PMID: 23833154]
  6. West J Nurs Res. 2021 Jul;43(7):677-685 [PMID: 33150841]
  7. Headache. 2016 May;56(5):821-834 [PMID: 27143127]
  8. Res Nurs Health. 1995 Aug;18(4):371-5 [PMID: 7624531]
  9. Neurol Sci. 2019 Jan;40(1):25-39 [PMID: 30306398]
  10. J Gen Intern Med. 2001 Sep;16(9):606-13 [PMID: 11556941]
  11. N Engl J Med. 1982 Aug 19;307(8):468-76 [PMID: 7048091]
  12. Cephalalgia. 2018 Jan;38(1):1-211 [PMID: 29368949]
  13. J Adv Nurs. 2008 Apr;62(1):107-15 [PMID: 18352969]
  14. J Headache Pain. 2014 Nov 27;15:79 [PMID: 25430992]
  15. Pain Physician. 2009 Jul-Aug;12(4):E225-64 [PMID: 19668283]
  16. Health Serv Res. 2007 Oct;42(5):1871-94 [PMID: 17850524]
  17. J Gen Intern Med. 2009 Apr;24(4):482-8 [PMID: 19189194]
  18. Appl Nurs Res. 2008 Aug;21(3):165-8 [PMID: 18684411]
  19. Acad Emerg Med. 2003 Nov;10(11):1239-48 [PMID: 14597500]
  20. Eur J Neurol. 2020 Mar;27(3):536-541 [PMID: 31574197]
  21. Expert Rev Med Devices. 2014 Sep;11(5):513-25 [PMID: 25033757]
  22. Drug Alcohol Depend. 2006 Feb 1;81(2):103-7 [PMID: 16023304]
  23. Headache. 2021 Jan;61(1):60-68 [PMID: 33349955]
  24. Arch Intern Med. 2004 Sep 13;164(16):1769-72 [PMID: 15364670]
  25. Headache. 2019 Apr;59(4):576-589 [PMID: 30957220]
  26. J Headache Pain. 2020 Jul 29;21(1):94 [PMID: 32727345]
  27. Pain Med. 2017 May 1;18(5):889-897 [PMID: 26995800]
  28. J Pain Res. 2021 Aug 24;14:2629-2639 [PMID: 34466030]
  29. Curr Pain Headache Rep. 2014;18(8):435 [PMID: 24916035]
  30. Headache. 2019 Jan;59(1):1-18 [PMID: 30536394]
  31. Pain Med. 2020 Nov 7;21(7):1331-1346 [PMID: 32259247]
  32. Headache. 2014 Jul-Aug;54(7):1131-45 [PMID: 24898930]
  33. Nurse Educ Today. 2004 Feb;24(2):105-12 [PMID: 14769454]
  34. J Pain. 2019 Jul;20(7):842-851 [PMID: 30690168]
  35. Int J MS Care. 2017 Sep-Oct;19(5):240-246 [PMID: 29070964]
  36. Br J Gen Pract. 2020 Jun 25;70(696):e514-e522 [PMID: 32482627]
  37. JAMA. 2009 Mar 11;301(10):1060-2 [PMID: 19278949]
  38. J Headache Pain. 2013 Dec 12;14:97 [PMID: 24330723]
  39. Pain Med. 2010 Mar;11(3):425-34 [PMID: 20002590]
  40. Pharmacogenomics. 2002 Sep;3(5):687-96 [PMID: 12223053]
  41. J Headache Pain. 2020 Jun 5;21(1):65 [PMID: 32503421]
  42. JAMA Intern Med. 2013 Mar 25;173(6):418-25 [PMID: 23440149]
  43. Comput Biomed Res. 1992 Aug;25(4):314-23 [PMID: 1511593]
  44. J Opioid Manag. 2011 Nov-Dec;7(6):427-33 [PMID: 22320024]
  45. Am J Public Health. 2014 Aug;104(8):e32-42 [PMID: 24922138]
  46. J Pain. 2007 Sep;8(9):682-91 [PMID: 17627894]
  47. MD Comput. 1986 Sep-Oct;3(5):34-48 [PMID: 3537611]
  48. Nurs Res. 1990 Mar-Apr;39(2):121-3 [PMID: 2315066]
  49. JAMA Neurol. 2020 Jun 1;77(6):683-690 [PMID: 32275288]
  50. J Gen Intern Med. 2002 May;17(5):327-33 [PMID: 12047728]

Word Cloud

Created with Highcharts 10.0.0DS-RPMpainusingheadachefacialPainclinicaluseevaluationusability/acceptabilityprimaryDecisionSupportToolResponsibleManagementhealthcareprovidersincludingtreatmenttestedquantitativeratings4datapracticeTestingvignettesdisorderdecisionsupportHeadacheFacialurgentcarecommonchallengingdiagnosemanageespeciallyopioidsappropriatelythereforedevelopedassistdiagnosismultiplesimultaneousdiagnosesworkuptriageopioid-risk-informedgoalsupplysufficientexplanationsDS-RPM'sfunctionsallowingcritiquedescribeprocessiterativelydesigningaddingcontenttesting/defectdiscoveryremotely21clinician-participantsthreevignettes-clustermigrainetemporalarteritis-afterfirsttrainingtrigeminal-neuralgiavignettequalitativesemi-structuredinterviewsused12Likert-typequestions1-5scale5representedhighestratingmeanranged4895SDsranging022-103ParticipantsinitiallyfoundstructuredentryintimidatingadaptedappreciatedcomprehensivenessspeedcaptureperceivedusefulteachingmakingseveralenhancementsuggestionsdesignedcreatedfacilitatebestmanagementpatientsheadachesshowedstrongfunctionalityhighRiskstratifyingopioiddevelopplanpossibletestingconsideredneedadapttoolsfuturedirectionsDiagnosisOpioid-Risk-StratifiedTreatmentClinicalOpioidVignettes

Similar Articles

Cited By (1)